Infectious Disease Alert – March 15, 2003
March 15, 2003
View Issues
-
Tenofovir in HIV/HBV-Coinfected Patients
Tenofovir effectively reduces HBV replication over 24 weeks of therapy in HIV-coinfected patients. -
Getting the Bugs Out of Bronchoscopes
Bacterial contamination of bronchoscopes, resulting in both unnecessary antibiotic use and clinical infection, resulted from a change in design of the instruments. -
Outpatient Antibiotic Use — France vs Germany: A Cultural Lesson
The French use antibiotics quite differently from the Germans, for a variety of reasons, including cultural factors and regulations, in addition to physician habits and patient expectations. -
More on MRSA: Long-Term Risk of Infection Following Acquisition
Twenty-nine percent of patients newly identified as carrying MRSA will have subsequent MRSA infection over the following 18 months. -
Antibiotic Susceptibility of Bacteroides fragilis Group Organisms
Metronidazole, piperacillin/tazobactam, and the carbapenems remain the most reliably active against B fragilis group organisms. -
Updates by Carol A. Kemper, MD, FACP
Updates